Katherine Eban

Eban interrogates the integrity of global pharmaceutical practices to uncover systemic fraud and hidden dangers. Her investigative journalism extends beyond mere reporting; it seeks to expose the deeply rooted problems in the pharmaceutical industry, particularly concerning the generic drug market. In her books like "Dangerous Doses" and "Bottle of Lies," Eban meticulously documents these issues, providing a narrative that challenges the status quo of drug manufacturing and distribution. These works emphasize the importance of accountability and transparency in powerful institutions, urging readers to critically evaluate the trustworthiness of pharmaceutical sources.\n\nIn parallel to her written work, Eban's articles for "Vanity Fair" and "Fortune" magazine broaden the scope of her inquiry into public health crises and covert government operations. Her exploration of topics such as pharmaceutical counterfeiting and the ethics of CIA interrogation techniques exemplifies her dedication to revealing the truths that impact public welfare and safety. This approach not only informs readers but also encourages policy changes and greater scrutiny within these sectors. The awards and recognition she has garnered, including the National Association of Science Writers award, underscore the impact of her findings on both national and international levels.\n\nFor readers interested in investigative journalism, Eban's bio provides a compelling case for the power of detailed research and fearless reporting. Her work benefits those seeking to understand the complexities and often concealed realities of the pharmaceutical world. Through her rigorous analysis and storytelling, Eban empowers audiences to demand higher standards of safety and ethics, both in medicine and beyond. This commitment to truth and integrity makes her an influential voice in journalism and a vital resource for those aiming to navigate the intricacies of public health and corporate accountability.